avital 4103lxl installation manual
LINK 1 ENTER SITE >>> Download PDF
LINK 2 ENTER SITE >>> Download PDF
File Name:avital 4103lxl installation manual.pdf
Size: 4982 KB
Type: PDF, ePub, eBook
Category: Book
Uploaded: 26 May 2019, 18:49 PM
Rating: 4.6/5 from 603 votes.
Status: AVAILABLE
Last checked: 16 Minutes ago!
In order to read or download avital 4103lxl installation manual ebook, you need to create a FREE account.
eBook includes PDF, ePub and Kindle version
✔ Register a free 1 month Trial Account.
✔ Download as many books as you like (Personal use)
✔ Cancel the membership at any time if not satisfied.
✔ Join Over 80000 Happy Readers
avital 4103lxl installation manualThe risk to health care professionals from handling a hazardous drug stems from its inherent toxicity and the extent to which workers are exposed to the drug. The primary routes of exposure are through direct skin contact and through inhalation of aerosolized drug products. Other potential exposure occurs during the disposal of the drugs, disposal of the items used in drug preparation and administration, and when caring for patients who have received these drugs. Health care professionals who handle chemotherapy are advised to be well informed of the potential health hazards, be familiar with safe handling and disposal of these agents, utilize appropriate protective equipment and adhere to available written policies, procedures and guidelines. The risks involved can be reduced significantly if one adheres to standard safety precautions while handling chemotherapy agents. This risk of exposure can be minimized by personal protective equipment (PPE), a needle-less system, and ventilation cabinets. Please refer to your institution’s policy on Pregnancy and exposure to chemotherapy agents. Following these guidelines will assist in minimizing unnecessary exposure and maximizing safety. These recommendations do not differentiate between high- and low-risk situations, as there is no known minimum safe exposure and always the potential for contamination. If satellite centres do not have a pediatric oncology orientation program, satellite nurses are to be trained and tested in chemotherapy administration at a tertiary centre. All Cytotoxic drugs and containers should have an appropriate label to alert handler of special precautions needed for handling. Establish a dedicated negative-pressure storage area for cytotoxic drugs that minimizes the risk of contamination.http://ecopromocionales.com/userfiles/bosch-pr20evsk-manual.xml
- Tags:
- avital 4103lxl installation manual, avital 4103lxl installation manual transfer switch, avital 4103lxl installation manual transmission, avital 4103lxl installation manual garage door opener, avital 4103lxl installation manual installation.
While the specific details of oncology pharmacy planning is beyond the scope of this document, details and some important considerations may be found in the Canadian Standard Association document CSA Z8000-11 (19) As a minimum, that emergency eyewash should be able to provide 15 minutes of flushing to both eyes. It is strongly recommended that a full shower be accessible nearby. It is strongly recommended that: The pad should not cover the front and rear grilles of the preparation cabinet and should be changed after 3.5 hours of continuous work; for a new batch of preparations or in the event of a spill or contamination. Limit the quantity of supplies and cytotoxic drugs in the cabinet, to avoid adversely affecting the laminar flow and to facilitate regular cleaning of the work surface; place the sterile products in the centre and the non-sterile products (e.g., waste receptacle) along the sides of the cabinet. For sterile preparations, adhere to aseptic technique for sterility. Use handling techniques that limit the risk of injury or accidental exposure. It is strongly recommended that: Cytotoxic drugs must display the “Cytotoxic” hazard symbol or the word “Cytotoxic”. It is strongly recommended that: Research has shown that gowns made of high-density polyethylene provide the most protective barrier against spillage or aerosolization of cytotoxic drugs (ONS, 1997, pg.6). Other suitable materials include polyurethane, neoprene or nitrile. It is strongly recommended that fit tested respirators such as NIOSH certified N95 or N100 be used to protect against airborne powder or aerosolized particles. Masks should be changed with obvious contamination as well as when it no longer seals to face. Chewing of gum in this area should not be allowed. A less desirable alternative is the availability of large volumes of saline solution for eye washing purposes. All needles, syringes and other disposable items should be disposed of in these.http://www.vannordenvastgoed.nl/userfiles/bosch-precision-wfg-2220-manual(1).xml Cap syringe and shake well to dislodge any remaining particles. Give dose in usual manner. This should be performed in a biohazard hood if possible. Examples include procarbazine, temozolomide, hydroxyurea: This should be performed in a biohazard hood if possible. While there is some data derived from the adult population, the extent to which this is applicable to children is unclear. Therefore, there is a real potential risk to health care professionals and parents who are caring for children following the administration of chemotherapy agents. It is suggested that PPE should be worn up to 48 hours post administration of intravenous (IV) chemotherapy agents and for up to 7 days post oral chemotherapy agents administration. These pads should be disposed of in biohazard containers after each use. This should be done by gowned and gloved health care personnel. All health care professionals who handle chemotherapy agents should be oriented and familiar with these policy and procedures. Oncology Nursing Society. Oncology Nursing Forum, 22 (3), 523. Mutation Research. 302(1):19-24, 1993 May. Implementing safe handling practices. Cancer. 70(4 Suppl):988- 992, 1992 Aug 15. Washington, DC: Office of Occupational Medicine. Safe Handling of Hazardous Drugs. Pittsburgh (PA): Oncology Nursing Society (ONS); 2003. 56 p The Online Journal of Knowledge Synthesis for Nursing, 7 (4). Toronto (ON): Cancer Care Ontario; 2013 December 4. Program in Evidence-Based Care Evidence-Based Series No.: 16-3. Is it safe for pregnant health-care professionals to handle cytotoxic drugs. A review of the literature and recommendations. 2014 Apr Safe Handling of Parenteral Cytotoxics: Recommendations for Ontario. JOP September 2009 vol. 5 no. 5 245-249. Clin J Oncol Nurs 2003;7(Suppl 6):25-9. Permeability of four disposable protective clothing materials to seven antineoplastic drugs. American Journal of Hospital Pharmacy. 42(11):2449-2454, 1985 Nov.http://www.drupalitalia.org/node/73026 Biomonitoring of nurses handling antineoplastic drugs. Mutation Research. 322(3):203-208, 1994 Sep. Oncology Nursing Forum. 21(7):1157-1165, 1994 Aug. Exposure of hospital pharmacists and nurses to antineoplastic agents. Journal of Occupational Medicine. 35(1):57-60, 1993 Jan. Safe handling of antineoplastic drugs: Results of a survey. Cancer Nursing. 17(6):501-511, 1994 Dec. British Journal of Industrial Medicine. 49(12):855- 861, 1992 Dec. Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing. 16(4):288-295, 1993 Aug. Reviewed by POGO Satellite Manual Review Nursing Group, 2016 and the POGO Satellite Manual Review Pharmacy Working Group, 2016. Risk categorization refers to risk of bacteremia and serious complications, including mortality. In addition, because chemotherapy is a hazardous product, staff safety during the preparation and administration processes also must be emphasized. Developing and implementing a comprehensive chemotherapy handling process is critical to ensuring medication and employee safety. Therefore, Dana-Farber Cancer Institute utilizes multiple checks to verify accurate chemotherapy preparation. After the pharmacist confirms the order, the label prints prompting the technician to assemble the required components—for example, some medications require filtering or special tubing. At the biological safety cabinet, the technician accesses the patient’s data in the computer and then scans the medication bar code label to ensure the correct medication and quantity has been selected for the right patient. After the technician draws up the drug and prior to injecting it into an IV bag, he or she uses a marker to specify the volume on the syringe for the pharmacist’s double check. The medication is then prepared, labeled, and placed in a sealed plastic bag for the pharmacist to review; the vials and syringe also are included in a separate bag.http://americanpatriotbeer.com/images/bose-av3-2-1ii-manual-1.pdf During the double check, the pharmacist can determine whether the technician performed an override or received a warning during the bar code scanning process. The pharmacist also can visually view the empty vials and syringe to verify the medication was prepared as intended. If the technician did not use all of the medication, he or she must include the remaining drug in the plastic bag so the pharmacist can perform a visual inspection of the leftover medication. Within the next year we anticipate enhancing our current process by adding digital photography of the various steps in the preparation process. This will allow a visual image of the vial, syringe volume, and final product to be viewed by a pharmacist during final product verification, as well as function as an audit tool. Some of the items it addresses include risk level determination of the sterile product, training and competencies required, preparing the sterile environment, and compounding accuracy checks.For example, in addition to delineating the correct method for delivering hazardous drugs to the nursing unit, include procedures for wasting these hazardous drugs. Specify the type of waste container that should be used, as well as what PPE should be donned during the disposal process. Employees should be required to sign a form stating they have received training and that they clearly understand the risks of handling hazardous materials. Be sure to include training procedures for environmental services staff if they will come into contact with hazardous materials Our facility uses a checklist containing all staff training requirements (see Technician Orientation Checklist). For example, employees must watch an ASHP chemotherapy preparation video, take USP and aseptic technique exams, and demonstrate correct use of our chosen CSTD. Include procedures for staff to follow to report safety concerns, such as equipment malfunctions, increased headaches, or recent changes in the environment.http://c2mag.com/wp-content/plugins/formcraft/file-upload/server/content/files/162712b5592d0e---boylestad-10th-edition-solution-manual-pdf.pdf Our policy specifies the employee speak with their supervisor, safety, or occupational health. The employee also provides occupational health with detailed information on which hazardous materials the employee has been working with so they can follow up with the employee directly and take appropriate action. In some cases occupational health may refer the employee to their own health care provider for testing Bartel: Standardizing chemotherapy concentrations wherever possible is prudent to decrease the possibility of calculation mistakes and ensure consistency. Determining which concentrations should be standardized is largely drug-dependent, so it is important to research the medications and dosages on formulary and identify what literature supports the concentration ranges used, in addition to any information provided by the approved manufacturers. In the guidelines we list the medication, the diluent, whether there is a particular manufactured IV bag we have to use (ie, an empty bag versus one that already has a solution in it), required tubings, filters, infusion rate information, and any special instructions for the pharmacist or technician (see Chemotherapy Reconstitution Chart). Bartel: Providing various types of training to staff and requiring both written testing and actual visual demonstration when evaluating staff proficiency will best ensure staff with different learning styles are provided information in a format that suits their needs. Our facility requires orientation training for new staff, as well as yearly training thereafter. In addition, regular direct observation of staff during the handling of these products is performed. Our hands-on training involves a pharmacist or experienced technician demonstrating proper technique for handling and preparing hazardous drugs with the technician repeating the correct procedure.chefjacklee.com/images/uploads/files/bread-machine-white-westinghouse-manual.pdf In addition, we utilize video training from ASHP that delineates how to safely handle hazardous medications and properly use safety equipment. Bartel: As chemotherapy is our facility’s primary service line, much of our staff has been trained and is competent to handle and prepare hazardous drugs. Beyond this, all of our technicians are nationally certified and are sufficiently experienced in sterile technique and compounding. Dana-Farber has one main campus and two satellite locations, which are within a 45- to 60-minute radius of the main facility. Our strategy to manage staff absences in all three locations is to cross-train employees so that in the event of an unexpected staff absence, we have a sufficient number of trained staff to fill in for any location. For hospitals with multiple service lines, ensuring adequate coverage during unexpected staff absences can be more difficult. Typically, the number of staff that has received appropriate training in chemotherapy handling and preparation is limited. Thus, much of this challenge can be offset by working closely with oncology providers when building staff schedules. Evaluate the number of patients scheduled during any expected staff absences and determine the volume of chemotherapy that will be required to provide appropriate staffing. She received her BS in pharmacy at the University of Wisconsin and an MS in public health from Northeastern University. Sylvia’s professional interests include oncology and therapeutic guideline development. Compliance with the OSHA hazard communication standard entails (1) evaluating whether these drugs meet one or more of the criteria for defining hazardous drugs and (2) posting a list of the hazardous drugs to ensure worker safety. Institutions may wish to compare their lists to the sample listing on the NIOSH Web site ( ).https://nicemexico.net/wp-content/plugins/formcraft/file-upload/server/content/files/162712b6312c8e---boylestad-introductory-circuit-analysis-10th-edition-solution-manual.pdf It is not likely that every health care provider or facility will use all drugs that have received US FDA approval, and the OSHA hazard communication standard does not mandate evaluation of every marketed drug. Instead, compliance requires practice-specific assessments for drugs used at any one time by a facility. However, hazardous drug evaluation is a continual process. Local hazard communication programs should provide for assessment of new drugs as they enter the marketplace, and when appropriate, reassessment of their presence on hazardous drug lists as toxicological data become available to support recategorization. Toxicological data are often incomplete or unavailable for investigational drugs. However, if the mechanism of action suggests that there may be a concern, it is prudent to handle them as hazardous drugs until adequate information becomes available to exclude them. With the increased availability of oral antineoplastic and other hazardous drugs, additional precautions are required in order to prevent worker exposure to these formulations. Some drugs defined as hazardous may not pose a significant risk of direct occupational exposure because of their dosage formulation (for example, coated tablets or capsules—solid, intact medications that are administered to patients without modifying the formulation). However, they may pose a risk if solid drug formulations are altered, such as by crushing tablets or making solutions from them outside a ventilated cabinet. All hazardous drugs, regardless of the formulation, should be labeled as such to prevent improper handling. Tablet and capsule forms of hazardous drugs should not be placed in automated counting machines, which subject them to stress and may introduce powdered contaminants into the work area. Counting and pouring of hazardous drugs should be done carefully, and clean equipment should be dedicated for use of these drugs.https://www.everhouse.lt/wp-content/plugins/formcraft/file-upload/server/content/files/162712b72291ec---boylestad-electronic-devices-and-circuit-theory-solution-manual-pdf.pdf Crushing tablets or opening capsules should be avoided and liquid formulations should be used whenever possible. During the compounding of hazardous drugs (eg, crushing dissolving, or preparing a solution or an ointment), workers should wear non-permeable gowns and double gloves. Compounding should take place in a ventilated cabinet whenever possible. Reference DHHS (NIOSH) Publication Number 2012-150 (Supersedes 2010-167) June 2012. Please log in or create a free account toVoid where prohibited by law. Odds of winning depend on the number of eligible entries received. For full official rules, click here. Sponsored by Ridgewood Medical Media LLC, 30 Garber Square, Suite A, Ridgewood, N.J. 07450. Not the least of these factors is finding, training, and retaining qualified staff willing to dedicate the time and discipline required for working with chemotherapy and other hazardous medications. Lee Memorial Health System, located in Fort Myers, Florida, comprises four acute care hospitals and two specialty hospitals. With a total of over 1420 beds, Lee Memorial is the largest public health system in Florida. Due to the scale of our operations, we opened the freestanding Regional Cancer Center (RCC) in the fall of 2008. This move centralized the majority of chemotherapy preparation and administration into one setting and allowed us to exert greater control over the processes of cancer treatment. Use It or Lose It As part of our initiative to bring chemotherapy management into a defined focus, we made a decision to only train certain staff in the attendant methods. This includes the pharmacists and technicians that prepare the medications, but also nurses who administer, couriers that transport, and housekeeping and waste management staff that deal with cleaning and maintaining our facilities.cgalgeria-dubai.com/userfiles/files/bread-machine-west-bend-manual.pdf Prior to opening the RCC, we attempted to train all pharmacy staff on chemotherapy preparation activities, but investing in training for staff who only occasionally work with chemotherapy proved inefficient, as this technical activity requires constant working experience. By training dedicated staff, we were able to develop a distinct group of chemotherapy management experts. They not only have the expertise in chemotherapy preparation, but also the expertise in assessing appropriateness of therapy and the need for supportive medications. This also is the reason we created a central location for all of our adult chemotherapy preparation that services all facilities in our health system. We now have four dedicated chemotherapy pharmacists at the cancer center, including myself, as well as 1.5 FTE technicians; these staff members work only with chemotherapy, all day, every day. Transition from Sterile to Cytotoxic Compounding Due to the rigorous nature of preparing and handling cytotoxic medications, oncology pharmacy technicians should be selected from the best of your staff. As with many large health systems, we have two levels of technician proficiency—technician 1 and technician 2—both of which have been certified through the PTCB; in order to work with chemotherapy at RCC, a technician must be at least a level 2. Further to eligibility and competency minimums, recruiting staff that have expressed an interest in oncology is paramount. These technicians must have already been trained in sterile compounding techniques, which eases the transition to compounding chemotherapy, as many of the concepts are the same. The main operational differences are direction of airflow—positive pressure for sterile, negative pressure for cytotoxic—and the type of hood used—a CACI for cytotoxic as opposed to a CAI or BSC for sterile compounding. Perhaps the most difficult aspect of transitioning from standard sterile compounding to cytotoxic compounding is becoming accustomed to working in a containment hood as opposed to a regular horizontal flow hood. However, this transition can be best facilitated through didactic, hands-on training. Considering the insidious nature of oncology medications, practitioners must take extra special care when working with them to avoid complacency. With this in mind, re-evaluating staff at least annually is highly recommended (see Figure 1). While these evaluations are usually conducted to prevent deterioration of technique, they also should be conducted when new products are added or handling guidelines change. To facilitate training, it is best to initiate a step-by-step process for chemotherapy preparation and administration. This not only should define processes for pulling the correct source products (eg, agent, diluent) and ensuring all labeling protocols are correct, but also creating profiles for every patient including the exact products made and administered, the day and time, the rate, and patient-specific information including name, date of birth, diagnosis, attending physician, height, weight, and BSA. In addition to this patient- and product-specific information, the pharmacist who checked the product, the protocol being used, and any special instructions for the order or mixing procedure are also documented. Comparison always should be made among the prepared IV bag label, the original order, and the patient profile to make sure everything matches up; all prepared chemotherapy agents also should be double checked prior to any agent being added to the final IV bag. All oncology pharmacists and technicians must be clear on the entire process from the time raw materials are selected to the time the final product comes out for delivery. To handle these cases, we keep a few oncology-trained pharmacists and technicians on each campus that have demonstrated competency in sterile preparation and have mastered the proper procedures for mixing chemotherapy. To augment this, we also developed a list of detailed guidelines for preparing specific items that is kept in a shared file on our intranet for oncology-related pharmacy operations. Effectively, these are step-by-step instructions, so if a stat order for bleomycin for pleural effusion is initiated at one of our hospitals, an on-site technician or pharmacist can pull that specific guideline and follow each step in proper order. As most non-RCC pharmacy staff prepare these items infrequently, it is unrealistic to expect them to remember every step. Instructions were created for the six medications that comprise the only hazardous or chemotherapy-related products prepared outside the RCC (with the exception of pediatric chemotherapy): Chemotherapy Stability Guidelines At RCC, we created a list of concentrations and stability information for all chemotherapy-related products for both pediatrics and adults. This includes standardized reconstitution instructions when possible. To develop this document, called Chemotherapy Stability Guidelines, we used the package inserts from individual drugs, as well as known drug references and information from the ASHP’s extended stability reference as our foundation. Following the publication of USP General Chapter, we incorporated its guidelines for stability and risk levels. Given the clarity of the guidelines establishing risk levels and beyond use dates, we have not had to update this document very often. Now, the guidelines list each medication, the diluent, the type of IV bag to use, and any special instructions. For example, intrathecals or vesicants have special stickers that must be applied to the bag to identify them accordingly. We make a point to update this document as new products or usage information is released, and our oncology-trained staff is cognizant of such updates. Keep in mind, all chemotherapy preparations are patient-specific with weight being a significant determining factor. The only products that are standardized and can be made ahead of time are items such as antiemetics or pre-medications. Prior to initiating the preparation of any chemotherapy dose, the patient first must be seen by the nurse and cleared for treatment through the assessment of the patient’s status and lab parameters. At that point, an oncology pharmacist reviews the lab results and any other pertinent information, and the technician then begins compounding the preparation. Managing Concentrations and Diluents Establishing the exact volume of the final product (IV bag volume) is acutely important for pediatric doses, so all pediatric IV bags are made using the automated compounder. For adult patients, establishing the exact final concentration or volume amount is not as critical. There are products that require a certain concentration for stability reasons, but otherwise we generally use the same amount of dilution for every adult patient. The challenge in making adult doses lies in the amount of medication we can fit in a single bag. With drugs like cisplatin that have a one-to-one concentration—1 mg per 1 mL—they are placed into an IV bag and then have mannitol added as well. Therefore, if the patient’s dose is 150 mg cisplatin plus 50 mL mannitol, there is not a lot of volume remaining in the bag for the diluent. To address this challenge, we prime every bag before adding any active chemotherapy agent, which makes it possible to draw out the same volume that we plan to put back in. Of course, this is conditional on whether the drug being prepared has any other special instructions. Creating Consistency Because chemotherapy preparation cannot be completely standardized, we rely on our specialized staffing approach along with documentation support to ensure proper procedure is always followed. For example, a limited number of tubing types are needed for chemotherapy administration, but special tubing is required for taxanes and infliximab (Remicade), and paclitaxel (Taxol) and docetaxel (Taxotere) both require non-DEHP tubing. So, in addition to listing the strengths and concentrations for each drug, the chemotherapy stability guidelines also specify special instructions such as these. Given that there will always be products with special preparation requirements, the value of having the same staff consistently preparing chemotherapy is clear. Relying on staff members who are not familiar with the tenets of compounding chemotherapy is far from ideal, but avoiding this situation is not always possible, so the chemotherapy stability guidelines provide necessary guidance. We make every effort to maintain all of our chemotherapy preparation and attendant processes at the RCC (pediatric chemotherapy being a notable exception), but in an emergency situation, a trained staff member who does not normally work in this area should be able to step in as there is a resource to refer to. Ultimately, centralizing these activities is particularly advantageous because it reduces waste and excess labor, and creating a dedicated staff for chemotherapy and other cytotoxic compounding allows a facility or health system to better control these complex and dangerous processes. Tina is a graduate of the University of the Sciences, College of Pharmacy, in Philadelphia and has been practicing oncology pharmacy for 20 years. Please log in or create a free account toVoid where prohibited by law. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others. Please try again.Please try again.Please try again. Please try your request again later. Between the hospital or clinic environment and the medical terminology used by doctors and health care professionals, you may feel as though you've entered a foreign country. Written by two experienced oncology nurses, this compassionate and comprehensive guide explains in plain English everything you need to know about your treatment, including what you can expect at each stage of chemotherapy and what you can do to prevent or minimize side effects. Packed with practical suggestions, nutritional advice, relaxation skills, and other techniques to help strengthen your body and calm your mind, The Chemotherapy Survival Guide is a must-have resource for anyone navigating this difficult time. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required. Show details. Ships from and sold by Amazon.com. In order to navigate out of this carousel please use your heading shortcut key to navigate to the next or previous heading. In order to navigate out of this carousel please use your heading shortcut key to navigate to the next or previous heading. Register a free business account Everything, including how to understand diagnoses, treatment plans, and emotional and social challenges, is beautifully written in layman’s terms so the patient can become an active partner in his or her own treatment. A must-read.” —Judith Shepherd, MSW, DSW, social worker at Alta Bates Summit Comprehensive Cancer Center “The previous edition of this comprehensive, well-written guide was enthusiastically received by patients, nurses, and physicians. This updated edition is even more valuable. It contains information relating to all aspects of a potentially difficult and frightening diagnosis.